Clinical Trial

Spinal Anesthesia Vs. Neve Block in Risk of Cognitive Decline

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Hip fracture is a potentially devastating event, and serious surgical and medical complications occur frequently especially for elderly patients. Delirium is one of the common complications after hip surgery. This study objective is to assess the association between type of anesthesia (nerve block vs. spinal anesthesia) and risk of cognitive decline (CD). And its secondary objective is to compare intra-operative hemodynamic changes, and post-operative pain. Prospective, double blind randomized clinical trial of hip fracture patients who will be assessed for CD pre- and postoperatively, for three months after surgery. Patients undergoing hip surgery will be randomized into two groups. Group 1 will receive unilateral lumbosacral nerve block (sciatic nerve block and paravertebral block at levels L3-L4 and L4-L5) as well as placebo injection (1 ml normal saline) at the spinal anesthesia level (L3-L4 or L4-L5). Group 2 will receive spinal anesthesia in addition to placebo injection at the sciatic, L3-L4 and L4-L5 levels.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-29.
Trial Details
NCT Number NCT06963229
Lead Sponsor Makassed General Hospital
Conditions Postoperative Cognitive Complications
Enrollment 50 participants
Start Date 2025-04-21
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-14